Abstract
This study aims to assess the relationship between chronic rhinosinusitis (CRS) and dyslipidemia in a Korean population. The population aged 40 years or over was selected from the Korean National Health Insurance Service-National Health Screening Cohort. CRS was defined if patients were treated ≥2 times with ICD-10 code (J32) and underwent head and neck computed tomography. Patients with CRS were classified as having nasal polyps (J33) or not. Dyslipidemia was defined if participants with the ICD-10 code (E78) were treated ≥2 times from 2002 to 2015. A total of 6163 patients with CRS were matched with 24,652 controls (1:4 ratio) for sex, age, income, and residence. The adjusted odds ratios (aORs) of a previous dyslipidemia in patients with CRS were analyzed by conditional logistic regression analysis, adjusted for confounding factors. The prevalence of dyslipidemia was significantly higher in participants with CRS (26.1%) than in the controls (20.6%) (p < 0.001). There was a significant positive association between CRS with/without nasal polyps and dyslipidemia (aOR = 1.36, 95%CI = 1.26–1.47, p < 0.001). The association between CRS and dyslipidemia was stronger for CRS without nasal polyps (aOR = 1.42, 95% CI = 1.28–1.57, p < 0.001) than for CRS with nasal polyps (aOR = 1.31, 95% CI = 1.17–1.47, p < 0.001). All age and sex subgroups exhibited consistent results. A personal history of dyslipidemia was associated with risk of CRS regardless of total cholesterol and the use of statins.
Highlights
Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease of the sinonasal mucosa
The prevalence of dyslipidemia was significantly higher in the chronic rhinosinusitis (CRS) patients (26.1%) than in the controls (20.6%) (p < 0.001)
There was a significant positive association between CRS and dyslipidemia
Summary
Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease of the sinonasal mucosa. The diagnosis of CRS often is based on clinical findings, including the duration of nasal symptoms, the characteristics of nasal discharge, and the presence of other symptoms. The endoscopic and/or computed tomography (CT) findings can distinguish between CRS with nasal polyps (CRScNP) and CRS without nasal polyps (CRSsNP) [1]. CRScNP has been associated with a type 2 inflammatory profile, while CRSsNP has been associated with a type 1 inflammatory profile [2,3]. The prevalence of CRS has been reported to range from 1% to 19% worldwide [4]. Some epidemiologic studies have reported relationships between CRS and components of metabolic syndrome, including obesity [8], diabetes [9], and hypertension [10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.